×
About 2,020 results
Feraheme® (ferumoxytol injection)
https://www.feraheme.com/

Feraheme® (ferumoxytol injection) for intravenous (IV) use: Indications and use

HEMLIBRA® (emicizumab-kxwh)
https://www.hemlibra.com/hcp.html

Discover FDA approved HEMLIBRA® (emicizumab-kxwh) for prophylactic treatment in Hemophilia A patients with or without factor VIII inhibitors. See BOXED WARNING.

ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder
https://www.alprolixpro.com/

ALPROLIX® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] keeps the future in mind for your patients with hemophilia B

ENDARI (L-glutamine oral powder)
https://www.endarirx.com/hcp

Now available for treatment of sickle cell disease in pediatric patients 5 years and older and the first in nearly 20 years for adults.

NUWIQ®, Antihemophilic Factor (Recombinant) Lyophilized Powder
https://www.nuwiqusa.com/hcp/

Learn more about NIWIQ, an antihemophilic factor (recombinant) for hemophilia A (factor VIII) treatment with no chemical modifications.

WILATE, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder
https://www.wilateusa.com/hcp/

Learn more about wilate, a von Willebrand Factor (VWF)/Factor VIII (FVIII) Complex for the treatment of patients with von Willebrand Disease (VWD)

ASPARLAS™ (calaspargase pegol - mknl) Prescribing Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761102s000lbl.pdf

Sections or subsections omitted from the full prescribing information are not listed. ASPARLAS is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years.

RYDAPT (midostaurin) capsules
https://www.hcp.novartis.com/products/rydapt/acute-myeloid-leukemia/efficacy/?site=43700018494138821&source=01030&msclkid=4bc92c44d27511b0fdd870df0b7d40cc&gclid=CP_1puOQo-ECFYL8swod5tADWg&gclsrc=ds

Find clinical trial information and efficacy data for RYDAPT for FLT3 mutation-positive acute myeloid leukemia (AML). See full Prescribing & Safety Info.

VYXEOS (daunorubicin and cytarabine)
https://vyxeospro.com/

View the official HCP site. FDA-approved liposome for the treatment of specific types of Acute Myeloid Leukemia (AML). See full Prescribing Information

PERJETA® (pertuzumab)
https://www.perjeta.com/hcp/breast-cancer.html

Learn about PERJETA®, indicated for early and metastatic HER2 positive breast cancer. Indications: Metastatic Breast Cancer. PERJETA® (pertuzumab) is indicated for use in combination with Herceptin® (trastuzumab) and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer (MBC) who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease. Earl...

POLIVY™ (polatuzumab vedotin) - Official Physician Site‎
https://www.polivy.com/hcp.html

Learn About Now Approved POLIVY™ & See If Treatment Is Right For Your Patients. Prescribing Information. Safety Information. Patient Financial Support. Clinical Trial Results. Types: Dosing and Administration, Warnings and Precautions, Contraindications. Diffuse Large Cell Lymphoma. B-cell Lymphoma

Captopril - captopril tablet-SANDOZ INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7141ba54-660c-49f7-ade2-e16d9aad11e9

Dec 15th, 2019 - Captopril tablets, USP are indicated for the treatment of hypertension. In using captopril tablets, consideration should be given to the risk of neutropenia/agranulocytosis (see WARNINGS). Captopril tablets may be used as initial therapy for patients with normal renal function, in whom the risk is relatively low. In patients with impaired renal function, particularly those with collagen vascula...

Givlaari - givosiran sodium injection, solution-Alnylam Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=167e663c-11e1-497b-a3fc-951d65d58eaa

Dec 11th, 2019 - GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP). GIVLAARI is an aminolevulinate synthase 1-directed small interfering RNA indicated for the treatment of adults with acute hepatic porphyria (AHP). (1)

Koate - antihemophilic factor (human) kit-KEDRION BIOPHARMA, INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=865df1e2-b4d1-dbf5-2899-a9c02df4d122

Dec 10th, 2019 - KOĀTE® is a human plasma-derived antihemophilic factor indicated for the control and prevention of bleeding episodes or in order to perform emergency and elective surgery in patients with hemophilia A (hereditary Factor VIII deficiency). Limitation of Use KOĀTE is not indicated for the treatment of von Willebrand disease. KOĀTE is a human plasma-derived antihemophilic factor indicated for the c...

Rydapt - rydapt capsule, liquid filled-Novartis Pharmaceuticals Corporation
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11fa3fc9-6776-49a6-b1c1-653f627c3e58

Dec 9th, 2019 - RYDAPT is a kinase inhibitor indicated for the treatment of adult patients with: Newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutation-positive as detected by an FDA-approved test, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation (1.1). Limitations of Use: RYDAPT is not indicated as a single-agent induction therapy for the treatment of...

Tranexamic acid - tranexamic acid injection, solution-Akorn, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cdf34cb8-e02b-402a-805b-51ae29e7320c

Dec 9th, 2019 - Tranexamic Acid Injection is indicated in patients with hemophilia for short-term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.

Solu-cortef - hydrocortisone sodium succinate injection, powder, for solution-Pharmacia and Upjohn Company LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=65eefd58-b166-4d71-ade6-45c8fdf86922

Dec 9th, 2019 - When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of SOLU-CORTEF Sterile Powder is indicated as follows: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic d...

Ninlaro - ixazomib capsule-Millennium Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b

Dec 9th, 2019 - NINLARO is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. (1)

Tranexamic acid - tranexamic acid injection, solution-Alvogen Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=296f5484-907b-0b95-ab65-3e108bf986ef

Dec 9th, 2019 - Tranexamic Acid Injection is indicated in patients with hemophilia for short-term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.

Imatinib mesylate - imatinib mesylate tablet, film coated-Golden State Medical Supply, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8b4106e3-74e1-41b0-a212-fb03fe9b3645

Dec 8th, 2019 - Imatinib mesylate tablets are a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase ( 1.1) Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of inte...